Trontinemab Speedily Clears Alzheimer’s Plaque
Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.
Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.
See why Cognito’s headset received FDA Breakthrough Device Designation for addressing cognitive and functional symptoms associated with Alzheimer’s.
Fiber improved performance in memory tests associated with early Alzheimer’s in just 12 weeks.
Fiber is cheap, available as over-the counter supplements, safe and just right for these cash-strapped times.
Scientists found a way to predict Alzheimer’s up to seven years before symptoms appear using A.I.
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
What do today’s Tsimane people have in common with ancient Greeks and Romans? A remarkably low rate of dementia. What’s their secret?
The BrainSee Alzheimer’s Test represents a cost-lowering advancement in diagnostics. It offers a fully non-invasive, convenient, and globally accessible screening solution.
What happened to brain networks and connectivity in older adults walking four days a week on a treadmill?
Find out how two biomarkers in saliva diagnose pain in dementia, effectively and non-invasively.
Lecanemab, the newest Alzheimer’s drug, is getting a boost by focusing ultrasound waves on the blood-brain barrier. Learn more about this next step in delivering better Alzheimer’s treatments.
VIDEOS + ARTICLE: Women are dangerously under-educated on female stroke risk. “Women do not think they are going to have a stroke. They think of it as a man’s disease,” said Dr. Greene-Chandos. Yet millions of women have strokes, often leading to vascular dementia. Learn what to look for and how to take action.
At Thailand’s Vivo Bene Dementia Resort, pampering is the priority. This special report for 60 MINUTES asks, why can’t there be facilities like Vivo Bene in Australia?
Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.
DEMENTIA is a group of symptoms common to over 50 disorders. Alzheimer’s disease is the most common type of dementia. Learn about the 10 most common types of dementia.
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
If you couldn’t see your mashed potatoes, you probably wouldn’t eat them. That’s why what “The Red Plate Study” found was astonishing! Alzheimer’s patients eating from red plates consumed 25 percent more food than those eating from white plates. Find out why.
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.